The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Neoadjuvant or definitive chemoradiotherapy (CRT) with carboplatin and paclitaxel (CP) in esophageal and junctional tumor: A geriatric oncologic perspective.
Jane Sze Yin Sui
No relevant relationships to disclose
MinYuen Teo
No relevant relationships to disclose
Joseph Martin
No relevant relationships to disclose
Cormac Small
No relevant relationships to disclose
Oliver J McAnena
No relevant relationships to disclose
Christopher Collins
No relevant relationships to disclose
Maccon M. Keane
No relevant relationships to disclose
Gregory D. Leonard
No relevant relationships to disclose